Literature DB >> 29549971

Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins.

Yamin Li1, Tao Yang2, Yingjie Yu1, Nicola Shi1, Liu Yang1, Zachary Glass1, Justin Bolinger1, Isaac James Finkel1, Wenhan Li1, Qiaobing Xu3.   

Abstract

Protein based therapeutics with high specificities and low off-target effects are used for transient and accurate manipulation of cell functions. However, developing safe and efficient carriers for intracellular delivery of active therapeutic proteins is a long-standing challenge. Here we report a combinatorial library of chalcogen (O, S, Se) containing lipidoid nanoparticles (LNPs) as efficient nanocarriers for intracellular delivery of negatively supercharged Cre recombinase ((-30)GFP-Cre) and anionic Cas9:single-guide RNA (Cas9:sgRNA) ribonucleoprotein (RNP) for genome editing. The structure-activity relationship between the lipidoids and intracellular protein delivery efficiencies was explored and it was demonstrated that the newly developed LNPs are effective for gene recombination in vivo.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Genome editing; Lipidoids; Protein delivery

Mesh:

Substances:

Year:  2018        PMID: 29549971     DOI: 10.1016/j.biomaterials.2018.03.011

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

1.  Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles.

Authors:  Yamin Li; Alice Chukun Li; Qiaobing Xu
Journal:  Adv Healthc Mater       Date:  2018-11-22       Impact factor: 9.933

2.  Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.

Authors:  Jin Chang; Xianghan Chen; Zachary Glass; Feng Gao; Lanqun Mao; Ming Wang; Qiaobing Xu
Journal:  Acc Chem Res       Date:  2018-12-26       Impact factor: 22.384

Review 3.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

4.  Protein and mRNA Delivery Enabled by Cholesteryl-Based Biodegradable Lipidoid Nanoparticles.

Authors:  Yamin Li; Rachel Jarvis; Kuixin Zhu; Zachary Glass; Roza Ogurlu; Peiyang Gao; Peixuan Li; Jinjin Chen; Yingjie Yu; Yongjie Yang; Qiaobing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-15       Impact factor: 15.336

Review 5.  Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.

Authors:  Yamin Li; Zhongfeng Ye; Hanyi Yang; Qiaobing Xu
Journal:  Acta Pharm Sin B       Date:  2022-04-27       Impact factor: 14.903

Review 6.  Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery.

Authors:  Justin M Horn; Allie C Obermeyer
Journal:  Biomacromolecules       Date:  2021-12-02       Impact factor: 6.978

Review 7.  Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.

Authors:  Yamin Li; Zachary Glass; Mingqian Huang; Zheng-Yi Chen; Qiaobing Xu
Journal:  Biomaterials       Date:  2020-01-10       Impact factor: 12.479

Review 8.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

9.  Combinatorial Library of Cyclic Benzylidene Acetal-Containing pH-Responsive Lipidoid Nanoparticles for Intracellular mRNA Delivery.

Authors:  Yamin Li; Raissa Li; Anirban Chakraborty; Roza Ogurlu; Xuewei Zhao; Jinjin Chen; Qiaobing Xu
Journal:  Bioconjug Chem       Date:  2020-06-24       Impact factor: 6.069

10.  Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.

Authors:  Tzu-Chieh Ho; Hye Sung Kim; Yumei Chen; Yamin Li; Mark W LaMere; Caroline Chen; Hui Wang; Jing Gong; Cal D Palumbo; John M Ashton; Hae-Won Kim; Qiaobing Xu; Michael W Becker; Kam W Leong
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.